Render Target: SSR
Render Timestamp: 2024-12-02T11:46:24.948Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-08-01 15:27:54.471
Product last modified at: 2024-05-30T07:06:12.674Z
1% for the planet logo
PDP - Template Name: Polyclonal Antibody
PDP - Template ID: *******59c6464

Phospho-TAZ (Ser89) Antibody #75275

Filter:
  • WB

Inquiry Info. # 75275

Please see our recommended alternatives.

    Supporting Data

    REACTIVITY H M Mk
    SENSITIVITY Endogenous
    MW (kDa) 55
    SOURCE Rabbit
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Protocol

    Specificity / Sensitivity

    Phospho-TAZ (Ser89) Antibody recognizes endogenous levels of TAZ protein only when phosphorylated at Ser89. Due to sequence similarities at this phosphorylation site, this antibody may also detect endogenous levels of YAP protein when phosphorylated at Ser127.

    Species Reactivity:

    Human, Mouse, Monkey

    The antigen sequence used to produce this antibody shares 100% sequence homology with the species listed here, but reactivity has not been tested or confirmed to work by CST. Use of this product with these species is not covered under our Product Performance Guarantee.

    Species predicted to react based on 100% sequence homology:

    Rat

    Source / Purification

    Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser89 of human TAZ protein. Antibodies are purified by protein A and peptide affinity chromatography.

    Background

    TAZ is a transcriptional co-activator with a PDZ-binding motif that is regulated by its interaction with 14-3-3 proteins (1). TAZ shares homology with the WW domain of Yes-associated protein (YAP) (1). TAZ is proposed to modulate the switch between proliferation and differentiation of mesenchymal stem cells (MSC) via interaction with transcription factors Runx2 and PPARγ. This process is critical to normal tissue development and the prevention of tumor formation. Due to its role in determination of MSC fate, TAZ may have clinical relevance to several human diseases caused by an imbalance of MSC differentiation (2,3). TAZ is negatively regulated via phosphorylation by LATS1/2, core kinases in the Hippo signaling pathway that controls stem cell development, tissue growth and tumor development (4).
    Phosphorylation of TAZ at Ser89 is hypothesized to destabilize TAZ protein by promoting 14-3-3 binding, cytoplasmic sequestration, and proteosomal degradation, thereby reducing the ability of TAZ to co-activate transcription of downstream target genes.
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.